Parkinson’s disease with early motor complications: predicting EQ-5D- 3L utilities from PDQ-39 data in the EARLYSTIM trial by Mehdi Zahra, Isabelle Durand-Zaleski, Michal Górecki, Silke Walleser Autiero, Gillian Barnett, W. M. Michael Schüpbach

Get full text

Using MDEFT MRI Sequences to Target the GPi in DBS Surgery. by Andreas Nowacki, Michael Fiechter, Jens Fichtner, Ines Debove, Lenard Lachenmayer, Michael Schüpbach, Markus Florian Oertel, Roland Wiest, Claudio Pollo

Get full text

T2-relaxometry predicts outcome of DBS in idiopathic Parkinson's disease by Tarja Lönnfors-Weitzel, MD, Thilo Weitzel, PhD, Johannes Slotboom, PhD, Claus Kiefer, PhD, Claudio Pollo, MD, Michael Schüpbach, MD, Markus Oertel, MD, Alain Kaelin, MD, PhD, Roland Wiest, MD

Get full text

Correction: Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial. by Andreas Hartmann, Julia Muellner, Niklaus Meier, Helke Hesekamp, Priscilla van Meerbeeck, Marie-Odile Habert, Aurélie Kas, Marie-Laure Tanguy, Merry Mazmanian, Hervé Oya, Nissen Abuaf, Hafida Gaouar, Sabrina Salhi, Fanny Charbonnier-Beaupel, Marie-Hélène Fievet, Damien Galanaud, Sophie Arguillere, Emmanuel Roze, Bertrand Degos, David Grabli, Lucette Lacomblez, Cécile Hubsch, Marie Vidailhet, Anne-Marie Bonnet, Jean-Christophe Corvol, Michael Schüpbach

Get full text

Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial. by Andreas Hartmann, Julia Müllner, Niklaus Meier, Helke Hesekamp, Priscilla van Meerbeeck, Marie-Odile Habert, Aurélie Kas, Marie-Laure Tanguy, Merry Mazmanian, Hervé Oya, Nissen Abuaf, Hafida Gaouar, Sabrina Salhi, Fanny Charbonnier-Beaupel, Marie-Hélène Fievet, Damien Galanaud, Sophie Arguillere, Emmanuel Roze, Bertrand Degos, David Grabli, Lucette Lacomblez, Cécile Hubsch, Marie Vidailhet, Anne-Marie Bonnet, Jean-Christophe Corvol, Michael Schüpbach

Get full text